Data as at IST. Index data may be delayed by up to 20 minutes. For real-time updates, kindly refer to the BSE and NSE websites.
Book Building - SME
₹ 13.02 cr
₹ 65 - 70
2000
₹ 1,30,000.00
BSE - SME
22-Sept-2025
24-Sept-2025
29-Sept-2025
Initial public issue of upto 18,60,000 equity shares of face value of Rs. 10/- each (Equity Shares) of Aptus Pharma Limited (the Company or Aptus or Issuer) at an issue price of Rs. [*] per equity share (Including a share premium of Rs.[*] per equity share) for cash, aggregating up to Rs. [*] crores (Public Issue) out of which 94,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the issue (the Market Maker Reservation Portion). The public issue less market maker reservation portion i.e. issue of 17,66,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating up to Rs.[*] crores is hereinafter referred to as the Net Issue. The public issue and net issue will constitute 27.11 % and 25.74 % respectively of the post-issue paid-up equity share capital of the company. Price Band: Rs. 65/- to Rs. 70/- for equity share of face value of Rs. 10 each.The floor price is 6.5 times times the face value and cap price is 7.0 times of the face value of the equity shares.Bids can made for a minimum of 4,000 equity shares and in multiples of 2,000 equity shares thereafter.
Capital Expenditure for Office Premises with furniture and Industrial Racks. Working Capital. General corporate purposes.
Aptus Pharma Ltd, Office No 56-2, Pinnacle Busine.Park, Mahakali Caves Road, Mumbai - 400093
Phone - 91-22-62638200
Fax - 91-22-63638299
Email - info@aptuspharma.com
Website - www.aptus-pharma.com